2m 2m 2m 2m 2m 2m 2m
Alkermes (ALKS)
NASDAQ
$48.34+$0.005 (+0.01%)
Price as of Aug 21, 2026 7:50 PM EDT- $8.0BMarket Cap
- 62.45%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Alkermes (ALKS)
$48.34+$0.005 (+0.01%)
ALKS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $48.33 | ||
Change | +$0.31 (+0.65%) | ||
Open | $48.05 | ||
High | $48.67 | ||
Low | $47.33 | ||
Previous Close | $48.02 | ||
Volume | 939,640 | ||
30-Day Average Volume | 1,630,099 | ||
1-Week Change | -1.49% | ||
1-Month Change | -8.55% | ||
1-Year Change | 62.45% | ||
3-Year Change | 63.06% | ||
5-Year Change | 59.77% | ||
Fundamentals | |||
Shares Outstanding | 164.8M | ||
Total Assets | $4.4B | ||
Market Cap | $8.0B | ||
Enterprise Value | $9.0B | ||
Period: QTR TTM FY | |||
Revenue | $411.7M | ||
Net Income | $501,000.00 | ||
Free Cash Flow | $137.0M | ||
EBIT | $5.5M | ||
EBITDA | $35.8M | ||
Net Working Capital | $860.8M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | 250 | ||
Enterprise Value/Revenue | 22 | ||
P/B | 4 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | 58 | ||
Price/Operating Cash Flow | 55 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue